1. Gamzu ER, Hoover TM, Gracon SI, Ninteman MV (1989) Recent developments in 2-pyrrolidinone-containing nootropics. Drug Dev Res 18: 177–189
2. Giurgea C, Salama M (1977) Nootropic drugs. Prog Neuropsychopharmacol 1: 235–247
3. Granik VG, Stezhko TV, Glushkov RG, Mashkovskii MD, Rashchina LF, Pletaeva AI, Parimbetova RB, Bobkov YuG, Losev AS, Ivanova IA (1988a) Preparation of 1-(thiocarbamoylmethyl) pyrrolidine-2-thione as a psychotropic agent. U.S.S.R. SU 1,414,845
4. Granik VG, Stezhko TV, Glushkov RG, Mashkovskii MD, Rashchina LF, Polezhaeva AI, Parimbetova RB, Bobkov YuG, Losev AS, Ivanova IA (1988b) Preparation of 1-(thiocarbamoylmethyl) pyrrolidine-2-thione with antihypoxic and nootropic activity. PCT. Int. Appl. WO 88 01, 620
5. Granik VG, Golovko TV, Glushkov RG, Mashkovskii MD, Roshchina LF, Polezhaeva AI, Parimbetova RB, Bobkov YuG, Losev AS, Ivanova IA (1989) Synthesis and pharmacological activity of 1-thio-carbamoylmethyl-pyrrolidine-2-thione. Khim Farm ZH 23(10): 1186–1193